How can single-use systems help manufacturers scale processes faster, and improve operational agility? How can they maintain product quality and regulatory compliance through precise measurement and robust data integrity? In an overview article by Endress and Hauser on single-use technology this is explained.
Single-use technology has fundamentally changed biopharmaceutical manufacturing by replacing rigid stainless-steel infrastructure with modular, disposable systems that enable rapid scale-up and scale-out. But agility only works when supported by precise measurement, standardized sensing, and strong data integrity. By combining SUT with reliable analytical instrumentation and digital traceability, manufacturers can scale with confidence while maintaining quality and compliance.
Taken together, these developments point towards a clear technical direction: fully closed, interconnected processing architecture that can ultimately support continuous operation. Achieving this requires more than disposable hardware – it depends on standardized flow paths, reliable inline measurement, robust control strategies and end-to-end data integrity. While adoption will remain hybrid and stepwise, these foundations enable manufacturers to move from isolated batch steps toward integrated, controlled process trains that reduce manual intervention, variability and operational risk.
Read the article
: https://www.endress.com/en/industry-expertise/life-sciences/single-use-technology-bioprocessing#toc00
Image caption: Lifecycle overview of a bioprocess, from development to scale-up, scale-out and digital execution. (© Endress + Hauser)
Bron: Endress + Hauser